Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dasco proprietary limited - nitric acid; sulfamic acid - aqueous concentrate - nitric acid acid-general active 206.0 g/l; sulfamic acid mineral-sulfur-acid active 54.0 g/l - dairy cleanser - milking equipment | milking machine - general disinfection | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | kennel | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

spick n clean products pty. ltd. - sodium dodecyl benzene sulfonate; potassium peroxomonosulfate triple salt; sodium chloride; sulfamic acid - powder - sodium dodecyl benzene sulfonate active, surfactant active 131.7 g/kg; potassium peroxomonosulfate triple salt active 494.0 g/kg; sodium chloride mineral-sodium-salt active 15.0 g/kg; sulfamic acid mineral-sulfur-acid other 50.0 g/kg - disinfectant - animal housing | vehicle - animal transport | cages | catteries | eggrooms | kennels | pens (sty) | poultry houses | stables - general disinfection | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | kennel | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls

Bangladesh - English - DGDA (Directorate General of Drug Administration)

navana pharmaceuticals ltd. - sulphachloropyridazine sodium + trimethoprim + vitamin k - powder - 100 mg + 20 mg + .8 mg/gm

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-synthelabo ireland ltd - mafenide - cream

Canada - English - Health Canada

mylan bertek pharmaceuticals inc. - mafenide (mafenide acetate) - cream - 8.5% - mafenide (mafenide acetate) 8.5% - miscellaneous local anti-infectives

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (united states) - mafenide acetate - cutaneous cream - 85mg/1gram

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

environex international pty ltd - sulfamic acid - powder - sulfamic acid mineral-sulfur-acid active 990.0 g/kg - dairy cleanser - milking equipment | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elmore chemicals - sulfamic acid(90g/l)+benzalkonium cl(53g/l) - aqueous - dairy cleanser - milking equipment | milking machine - residue, dirt in milking equipment

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 50 mg in 1 ml - dogs, cats & horses: salix® is an effective diuretic possessing a wide therapeutic range. pharmacologically it promotes the rapid removal of abnormally retained extracellular fluids. the rationale for the efficacious use of diuretic therapy is determined by the clinical pathology producing the edema. salix® is indicated for the treatment of edema, (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema. the continued use of heart stimulants, such as digitalis or its glycosides is indicated in cases of edema involving cardiac insufficiency. cattle: salix® is indicated for the treatment of physiological parturient edema of the mammary gland and associated structures. salix® is a highly effective diuretic-saluretic which if given in excessive amounts may result in dehydration and electrolyte imbalance. therefore, the dosage and schedule may have to be adjusted to the patient's needs. the animal should be observed for early signs of electrolyte imbalance, a

United States - English - NLM (National Library of Medicine)

roerig - trovafloxacin mesylate (unii: 0p1lko80wn) (trovafloxacin - unii:9f388j00uk) - tablet, film coated - 100 mg - trovan is indicated for the treatment of patients initiating therapy in in-patient health care facilities (i.e., hospitals and long term nursing care facilities) with serious, life- or limb-threatening infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration .) nosocomial pneumonia caused by escherichia coli, pseudomonas aeruginosa, haemophilus influenzae , or staphylococcus aureus . as with other antimicrobials, where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with either an aminoglycoside or aztreonam may be clinically indicated. community acquired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, klebsiella pneumoniae, staphylococcus aureus, mycoplasma pneumoniae, moraxella catarrhalis, legionella pneumophila, or chlamydia pneumoniae . complicated intra-abdominal infections, including post-surgical infections caused by escherichia coli, bacteroides fragilis, vir